Article
Targeting Histone Deacetylase 6 Reprograms Interleukin‐17‐Producing Helper T Cell Pathogenicity and Facilitates Immunotherapies for Hepatocellular Carcinoma
20 Sept 2019
Abstract excerpt
Background and Aims Hepatocellular carcinoma (HCC) is often accompanied by resistance to immunotherapies despite the presence of tumor‐infiltrating lymphocytes. We report that histone deacetylase 6 (HDAC6) represses interleukin‐17 (IL‐17)–producing helper T (T H 17) cell pathogenicity and the antitumor immune response, dependent on its deacetylase activity. Approach and Results Adoptive transfer of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
